Revvity, Inc
A health science company that makes the tools, instruments, and software used in drug discovery and medical diagnostics — from lab automation and reagents to newborn-screening tests that have checked hundreds of millions of babies. Its roots reach back to PerkinElmer, founded in 1937 by an investment banker and a court reporter who bonded over astronomy. In 2023 the life-sciences and diagnostics arm took the name Revvity, a blend of "revolutionize" and the Latin "vita," meaning life.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 13G/APassive | 16.4% | 18.27M | Aug 14, 2026 |
| T. Rowe Price Associates, Inc. | 13G/APassive | 5% | 5.53M | Aug 14, 2026 |
| Vanguard Capital Management | 13GPassive | 7.44% | 8.33M | Apr 30, 2026 |
| The Vanguard Group | 13G/APassive | 0% | 0 | Mar 27, 2026 |
| EdgePoint Investment Group Inc. | 13G/APassive | 7.39% | 8.57M | Nov 14, 2025 |
| JANUS HENDERSON GROUP PLC | 13G/APassive | 6.6% | 7.63M | Nov 14, 2025 |